US officials have said that the Moderna vaccine against the Corona virus may be ready for use by the end of the year, Al Arabiya reported.
And today began the first tests of the third and final stage of the clinical trials of the emerging vaccine against the Coronavirus, which is expected to be carried out by 30 thousand volunteers. According to the Associated Press, there is as yet no guarantee that the experimental vaccine, developed by the US National Institutes of Health and the Moderna Biotechnology Company, will really protect against the virus.
The volunteers will not know if they are getting a real dose or a fake dose. After two doses, scientists will closely follow any group that suffers more infections during their daily routine, especially in areas where the virus is still widespread. “Moderna” said that the trials started in the city of Savannah, Georgia, the first location in which the vaccine will be tested out of more than seven sites throughout the country.
The results of the first stage of the vaccine had shown that it was generally safe, and caused immune reactions in all volunteers, but it had some side effects, such as headache, fatigue, and muscle pain.
The results of the first stage of the vaccine had shown that it was generally safe, and caused immune reactions in all volunteers, but it had some side effects, such as headache, fatigue, and muscle pain. And yesterday (Sunday), “Moderna” said that it obtained an additional $ 472 million from the US government’s Department of Biomedical Development and Advanced Research in developing the vaccine, after it had received in April of $ 483 million from the authority when it was The vaccine is at an early stage. Many other vaccines made by China and Britain’s Oxford University earlier this month began final-stage tests on fewer volunteers in Brazil and other severely affected countries.
Dr. Larry Currie, a virologist at the Fred Hutchinson Cancer Research Institute in Seattle, said that more than 150,000 Americans have registered their data online in recent weeks to participate in vaccine research. Corrie noted that vaccine experiments “should be conducted on different generations, with multiple races, and should reflect the diversity of the United States population.” He stressed that «it is particularly important to ensure the participation of a sufficient number of black and Latin volunteers; Because this population is the most affected by (Corona)